NEU 2.81% $18.65 neuren pharmaceuticals limited

retts syndrome, page-31

  1. 2,647 Posts.
    lightbulb Created with Sketch. 432
    Here's another case where I'm going to rely on those with better memoried than me. I have had a quick trawl through the web but couldn't find a definitive answer.

    Do we know if there's an intrention or a nominal plan for a pediatric trial for Rett/2566 following the current phase II adult trial?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.